Curis, Inc. (NASDAQ:CRIS) last session’s volume of 1.56 million shares was lower than its average volume of 1.57 million shares. The stock, after opening at $0.7, hit $0.7 through the close by scoring 1.64%.Curis, Inc. (CRIS) Analyst Opinion
Curis, Inc. has a consensus buy rating from 4 Wall Street analysts, and the number of shares currently sold short amount to at least 1.12% of shares outstanding. The stock sank -14.48% last month and is up 0.19 this year. Wall Street is only getting more bullish on the stock, with 4 of analysts who cover CRIS having a buy-equivalent rating. Analysts have placed a $5.5 price target on Curis, Inc., suggesting a 685.71% gain from recent close. It’s currently trading about -78.22% below its 52-week high.Curis, Inc. Earnings Surprise
Curis, Inc. (CRIS) failed to surprise the stock market in its last reported earnings when it earned -$0.11 a piece versus the consensus-estimated -$0.09. Its revenue totaled $2.19 million up 6.31% from the previous quarter.
This stock (CRIS) is ahead of its 52-week low with 4.64%. Its last month’s stock price volatility remained 6.42% which for the week stands at 6.34%. The share price has moved backward from its 20 days moving average, trading at a distance of -5.97% and stays -25.29% away from its 50 days moving average. Over the last five days, shares have faced -4.47% losses and now is down -58.56% since hitting its 200-day moving average of $1.4903. Curis, Inc. (CRIS) has made its way to a 12-month decline of -76.7%.
Turning to Natus Medical Incorporated (NASDAQ:BABY), its shares were trading at $29 a gain of $0.4, on the trading floor. The stock, after opening at $28.45, touched a high of $29.45 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Natus Medical Incorporated has 1 buy ratings, 2 holds and 0 sells even after the stock tumbled -33.49% from its high of $43.60 to a $923.36 million market value through last close.Natus Medical Incorporated (BABY) Consensus Price Target
The company’s consensus rating on Reuter’s scale improved from 1.67 to 2.33 during a month. Analysts set a 12-month price target of $55 a share. The target implies a 89.66% spike from where the shares are currently trading. Also, the current price highlights a discount of 89.66% to analysts’ high consensus price target.Natus Medical Incorporated (NASDAQ:BABY) Intraday Trading
The counter witnessed a trading volume of 1.82 million shares versus an average volume of 0.44 million shares during last trading session. Its last month’s stock price volatility remained 5.23% which for the week approaches 3.18%. The lowest price the stock reached in the last trading day was $28.4 and compares with the $28.40 52-week low. The stock recovered 2.11% since its low point and has performed -24.08% year-to-date.